Candida auris is a novel and emerging pathogenic yeast which represents a serious global health threat. Since its first description in Japan 2009, it has been associated with large hospital outbreaks all over the world and is often resistant to more than one antifungal drug class. To date, five C. auris isolates have been detected in Austria. Morphological characterization and antifungal susceptibility profiles against echinocandins, azoles, polyenes and pyrimidines, as well as the new antifungals ibrexafungerp and manogepix, were determined. In order to assess pathogenicity of these isolates, an infection model in Galleria mellonella was performed and whole genome sequencing (WGS) analysis was conducted to determine the phylogeographic origin. We could characterize four isolates as South Asian clade I and one isolate as African clade III. All of them had elevated minimal inhibitory concentrations to at least two different antifungal classes. The new antifungal manogepix showed high in vitro efficacy against all five C. auris isolates. One isolate, belonging to the African clade III, showed an aggregating phenotype, while the other isolates belonging to South Asian clade I were non-aggregating. In the Galleria mellonella infection model, the isolate belonging to African clade III exhibited the lowest in vivo pathogenicity. As the occurrence of C. auris increases globally, it is important to raise awareness to prevent transmission and hospital outbreaks.

Antifungal susceptibility testing is important in guiding patient therapy due to an increasing number of resistant Candida isolates. In the clinical strain collection of the Austrian resistance report (AURES), a high number of micafungin-resistant C. albicans isolates (18.2% 49/269) was detected in seven different centres in Austria from 2011–2016. Most of these isolates showed a micafungin MIC value that was just above the clinical breakpoint (CB) established by EUCAST (0.016 mg/L). The aim of this study was to analyse whether C. albicans strains showing a micafungin MIC value of 1–2 dilutions above the CB (0.032 mg/L and 0.064 mg/L) are associated with mutations in FKS1 hotspot (HS) regions. 115 C. albicans candidemia strains showing a micafungin MIC one or two dilutions above the EUCAST CB (0.032 mg/L and 0.064 mg/L) were categorized as borderline resistant and screened for mutations in FKS1 HS1, HS2, and HS3 regions, which are known locations for the development of echinocandin resistance. For this purpose, we implemented targeted resequencing utilizing a next generation sequencing technology. No missense mutations could be detected in FKS1 HS1, HS2, and HS3 in any of the 115 isolates, which indicated that resistance conferred by alteration of FKS1 seems unlikely.

Background: In the environment, microbial communities are constantly exposed to invasion by antimicrobial resistant bacteria (ARB) and their associated antimicrobial resistance genes (ARGs) that were enriched in the anthroposphere. A successful invader has to overcome the biotic resilience of the habitat, which is more difficult with increasing biodiversity. The capacity to exploit resources in a given habitat is enhanced when communities exhibit greater diversity, reducing opportunities for invaders, leading to a lower persistence. In the context of antimicrobial resistance (AMR) dissemination, exogenous ARB reaching a natural community may persist longer if the biodiversity of the autochthonous community is low, increasing the chance of ARGs to transfer to community members. Reciprocally, high microbial diversity could serve as a natural long-term barrier towards invasion by ARB and ARGs. Results: To test this hypothesis, a sampling campaign across seven European countries was carried out to obtain 172 environmental samples from sites with low anthropogenic impact. Samples were collected from contrasting environments: stationary structured forest soils, or dynamic river biofilms and sediments. Microbial diversity and relative abundance of 27 ARGs and 5 mobile genetic element marker genes were determined. In soils, higher diversity, evenness and richness were all significantly negatively correlated with the relative abundance of the majority (>85%) of ARGs. Furthermore, the number of detected ARGs per sample was inversely correlated with diversity. However, no such effects were found for the more dynamic, regularly mixed rivers. Conclusions: In conclusion, we demonstrate that diversity can serve as barrier towards AMR dissemination in the environment. This effect is mainly observed in stationary, structured environments, where long-term, diversity-based resilience against invasion can evolve. Such barrier effects can in the future be exploited to limit the environmental proliferation of AMR.

Human studies involving exposure to trifluoroacetic acid (TFA) and the associated clinical outcomes are typically not considered in standard chemical toxicity assessments. This review aimed to identify and synthesize all available human data on TFA exposure, regardless of study design or context. Given TFA’s long-standing use and its formation as a degradation product of various compounds, a wide range of exposure scenarios was considered, including post-anesthesia monitoring, environmental assessments, and chemical incidents. The database searches in MEDLINE (PubMed) and EMBASE (Scopus) were conducted on 28 and 29 April 2025. A total of 17 studies met the inclusion criteria: 4 case reports, 3 case series, 5 observational studies, and 5 pharmacokinetic studies. All studies documented clear human exposure to TFA and reported at least one TFA-related outcome. Some acute exposures exceeded the currently proposed threshold values. However, no study demonstrated clinically relevant effects attributable to TFA. As a strong acid, TFA can cause typical corrosive injuries upon direct contact, but no additional systemic or organ-specific toxic effects were observed.

Plant-derived foods are potential vehicles for microbial antibiotic resistance genes (ARGs), which can be transferred to the human microbiome if consumed raw or minimally processed. The aim of this study was to determine the prevalence and the amount of clinically relevant ARGs and mobile genetic elements (MGEs) in differently processed smoothies (freshly prepared, cold-pressed, pasteurized and high-pressure processed) and fresh produce samples (organically and conventionally cultivated) to assess potential health hazards associated with their consumption. The MGE ISPps and the class 1 integron-integrase gene intI1 were detected by probe-based qPCR in concentrations up to 10⁴ copies/mL in all smoothies, lettuce, carrots and a single tomato sample. The highest total (2.2 × 10⁵ copies/mL) and the most diverse ARG and MGE loads (16/26 targets) were observed in freshly prepared and the lowest prevalences (5/26) and concentrations (4.1 × 10³ copies/mL) in high-pressure-processed (HPP) smoothies. Bla_CTX-M-1-15 (1.2 × 10⁵ c/mL) and strB (6.3 × 10⁴ c/mL) were the most abundant, and qacEΔ1 (95%), bla_TEM1 (85%), ermB and sul1 (75%, each) were the most prevalent ARGs. QnrS, vanA, sat-4, bla_KPC, bla_NDM-1 and bla_OXA-10 were never detected. HPP treatment reduced the microbial loads by ca. 5 logs, also destroying extracellular DNA potentially encoding ARGs that could otherwise be transferred by bacterial transformation. The bacterial microbiome, potential pathogens, bacterial ARG carriers and competent bacteria able to take up ARGs were identified by Illumina 16S rRNA gene sequencing. To reduce the risk of AMR spread from smoothies, our data endorse the application of DNA-disintegrating processing techniques such as HPP.

Dermatophytes cause a wide range of superficial infections of the skin, hair and nails, with high global prevalence and considerable public health relevance. Treatment regimens for dermatophytosis are limited to few antifungal drug classes, and rising resistance—particularly to terbinafine—further compromises therapeutic efficacy. Topical antiseptics such as octenidine (OCT) may represent a promising option for infection control and local therapy. This study investigated the in vitro antifungal activity of the pure antiseptic OCT (at final assay concentrations of 0.1% and 0.05%) and two OCT-based commercial ready-to-use medicinal products (octeniderm® and octenisept®) against clinical isolates of emerging (drug-resistant) dermatophytes including Trichophyton rubrum, T. mentagrophytes, T. tonsurans, T. interdigitale, T. indotineae and Microsporum canis . Quantitative suspension assays were conducted according to EN 13624:2013 under low organic load (0.3 g/L bovine serum albumin) and high organic load (3 g/L bovine serum albumin, 3 mL/L defibrinated sheep blood), with contact times ranging from 1 to 15 min. Results showed that the active OCT itself as well as the skin antiseptic octeniderm® and the wound and mucous membrane antiseptic octenisept® are effective against the tested dermatophytes in a time- and concentration-dependent manner. Notably, octeniderm® was able to inhibit fungal growth within 1 min, even under high organic load conditions. These in vitro findings suggest that OCT, a well-tolerated antiseptic already in clinical use represents a potential option for preventing transmission and managing superficial infections caused by (drug-resistant) dermatophytes